Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus

被引：0
|
作者：
C C Dvorak
E Callard
R Agarwal
机构：
[1] Stanford University School of Medicine,Division of Pediatric Stem Cell Transplantation
来源：
Bone Marrow Transplantation | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 254
页数：1
相关论文
共 50 条
  • [21] Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience
    Hashmi, Hamza
    Bhandari, Shruti
    Dhanoa, Jugraj
    Wu, Xiaoyong
    Rai, Shesh
    Figg, Lindsay
    Baize, Timothy
    Krem, Maxwell
    Hegazi, Mohamed
    Emmons, Robert
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [22] Efficacy of Tacrolimus/Mycophenolate Mofetil as Acute Graft-Versus-Host Disease Prophylaxis and the Impact of Subtherapeutic Tacrolimus Levels in Children after Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
    Offer, Katharine
    Kolb, Michelle
    Jin, Zhezhen
    Bhatia, Monica
    Kung, Andrew L.
    George, Diane
    Garvin, James H.
    Robinson, Chalitha
    Sosna, Jean
    Karamehmet, Esra
    Satwani, Prakash
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 496 - 502
  • [23] A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
    Torlen, Johan
    Ringden, Olle
    Garming-Legert, Karin
    Ljungman, Per
    Winiarski, Jacek
    Remes, Kari
    Itala-Remes, Maija
    Remberger, Mats
    Mattsson, Jonas
    [J]. HAEMATOLOGICA, 2016, 101 (11) : 1417 - 1425
  • [24] Maximizing the Benefits of Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis
    Hamilton, Betty Ky
    Kalaycio, Matt
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1869 - 1870
  • [25] A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation
    Nash, RA
    Johnston, L
    Parker, P
    McCune, PS
    Storer, B
    Slattery, JT
    Furlong, T
    Anasetti, C
    Appelbaum, FR
    Lloid, ME
    Deeg, HJ
    Kiem, HP
    Martin, PJ
    Schubert, MM
    Witherspoon, RP
    Forman, SJ
    Blume, KG
    Storb, R
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (07) : 495 - 505
  • [26] Mycophenolate mofetil for treatment of graft-versus-host disease following stem cell transplantation when cyclosporine is contraindicated
    Rzepecki, P
    Batiuk, B
    Zolnierek, J
    Sarosiek, T
    Bartczak, E
    Szczylik, C
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S310 - S310
  • [27] Population pharmacokinetic modeling of vedolizumab for graft-versus-host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant
    Waterhouse, Timothy
    Baron, Kyle
    Eure, Westley
    Chen, Chunlin
    Dirks, Nathanael L.
    Jansson, Johan
    Akbari, Mona
    Mehrotra, Shailly
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (05):
  • [28] Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
    Moiseev, Ivan S.
    Pirogova, Olga V.
    Alyanski, Alexandr L.
    Babenko, Elena V.
    Gindina, Tatyana L.
    Darskaya, Elena I.
    Slesarchuk, Olga A.
    Bondarenko, Sergey N.
    Afanasyev, Boris V.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (06) : 1037 - 1042
  • [29] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
    Mattsson, J.
    Svenberg, P.
    Gustafsson, B.
    Remberger, M.
    Ringden, O.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
  • [30] Tacrolimus versus cyclosporine A in prophylaxis of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
    Stankevich, Y.
    Zubarovskaya, L.
    Vavilov, V.
    Bondarenko, S.
    Darskaya, E.
    Kulagin, A.
    Afanasyev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S153 - S154
12345